Asymmetrical Fc Engineering Greatly Enhances Antibody-dependent Cellular Cytotoxicity (ADCC) Effector Function and Stability of the Modified Antibodies-Reference-Cited by-同舟云学术

Asymmetrical Fc Engineering Greatly Enhances Antibody-dependent Cellular Cytotoxicity (ADCC) Effector Function and Stability of the Modified Antibodies

Published:2014-02 Issue:6 Volume:289 Page:3571-3590
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Liu Zhi,Gunasekaran Kannan,Wang Wei,Razinkov Vladimir,Sekirov Laura,Leng Esther,Sweet Heather,Foltz Ian,Howard Monique,Rousseau Anne-Marie,Kozlosky Carl,Fanslow William,Yan Wei

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference36 articles.

1. Development trends for monoclonal antibody cancer therapeutics;Reichert;Nat. Rev. Drug Discov,2007

2. Fcγ receptors as regulators of immune responses;Nimmerjahn;Nat. Rev. Immunol,2008

3. The IgG Fc receptor family;Gessner;Ann. Hematol,1998

4. Therapeutic activity of humanized ant-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene;Cartron;Blood,2002

5. Immunoglobin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with Her-2/neu-positive metastatic breast cancer;Musolino;J. Clin. Oncol,2008

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fc engineering by monoclonal mammalian cell display for improved affinity and selectivity towards FcγRs;Antibody Therapeutics;2024-06-21

2. Study on the S239D/I332E mutation effect on the kinetics of Fc–Fc receptor binding through transition complex theory;Biotechnology and Bioprocess Engineering;2024-04-22

3. IgG Structure and Function;Reference Module in Life Sciences;2024

4. Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa;Cell;2023-11

5. Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic;Molecular Cancer Therapeutics;2023-04-17